Cysteine pathways help T cells choose between multiplying and attacking tumors

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health has discovered how the immune system’s CD8+ T cells use the nutrient cysteine to control two essential functions that compete for this resource—the immune cell’s ability to multiply and its ability to kill cancer cells.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup